The Week In Cannabis: The Vape Craze, Raises Hit $10B, Aurora Cashes In On TGOD, Seth Rogen's Charity Goes Green – Yahoo Finance

The vape craze took over the news this week, as the U.S. debated the perils of vaporized marijuana, following an outbreak of vaping-associated lung illnesses. On Thursday, the New York State Department of Health came out with a theory around vitamin E acetate being the culprit. Meanwhile, Washington, D.C. enacted a law that provides protections to government employees who consume medical marijuana.

On the markets front, we learned cannabis-related capital raises, deals and M&A transactions had almost hit $10 billion this year through the end of August. This number compares to roughly $5.5 billion raised over the same period of time last year. Cultivation and retail subsegments of the industry continued to attract the majority of investments, same as in previous years.

While many were investing in the cannabis space, Aurora Cannabis Inc. (NYSE: ACB) has started cashing out on some of its investments. On Wednesday, the company said it had sold all of its remaining shares of The Green Organic Dutchman Holdings Ltd (OTC: TGODF) (TSE: TGOD). The stake, comprised of 28.83 million TGOD shares, accounted for 10.5% of the total number of outstanding shares. Sold at a price of $3.00 per share, Aurora received gross proceeds of $86.5 million. Even though Aurora doesn’t own any TGOD shares any longer, it still owns warrants to purchase 16.67 million shares in the future.

If you want to get this news recap in your email inbox every week, please subscribe to https://tinyletter.com/javierhasse

Debra Borchardt, CEO of Green Market Report, highlighted Aurora’s 50% return on its TGOD investment.

“Why sit on this money if you can use it, right?” she asks. “However, I worry that Aurora is going to need even more money as it waits for its numerous acquisitions to pay off.”

Click here for more information about the upcoming Benzinga Cannabis Capital Conference

Read More Here...

Leave a Comment

Please Rate This Content*

Your email address will not be published. Required fields are marked *

Scroll to Top